Hill-Rom Holdings Inc (HRC) Lowered to Hold at ValuEngine

ValuEngine cut shares of Hill-Rom Holdings Inc (NYSE:HRC) from a buy rating to a hold rating in a research report released on Saturday morning.

Several other brokerages also recently commented on HRC. Zacks Investment Research raised Hill-Rom Holdings from a hold rating to a buy rating and set a $90.00 target price on the stock in a report on Friday, October 27th. KeyCorp reissued a buy rating and issued a $82.00 target price on shares of Hill-Rom Holdings in a report on Tuesday, October 17th. Stifel Nicolaus reissued a buy rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a report on Sunday, July 30th. BidaskClub raised Hill-Rom Holdings from a sell rating to a hold rating in a report on Sunday, August 6th. Finally, Needham & Company LLC reduced their target price on Hill-Rom Holdings from $95.00 to $93.00 and set a buy rating on the stock in a report on Friday, July 28th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock currently has an average rating of Buy and an average target price of $87.29.

Hill-Rom Holdings (HRC) traded down $2.50 during midday trading on Friday, reaching $77.50. The company’s stock had a trading volume of 1,219,951 shares, compared to its average volume of 446,033. The company has a quick ratio of 1.33, a current ratio of 1.76 and a debt-to-equity ratio of 1.67. The company has a market capitalization of $5,104.46, a price-to-earnings ratio of 20.07, a P/E/G ratio of 1.60 and a beta of 1.19.

Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.05. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $731.10 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.18 earnings per share. equities analysts predict that Hill-Rom Holdings will post 4.26 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Hill-Rom Holdings Inc (HRC) Lowered to Hold at ValuEngine” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.com-unik.info/2017/11/05/hill-rom-holdings-inc-hrc-lowered-to-hold-at-valuengine.html.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the company’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total transaction of $532,287.60. Following the completion of the sale, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,293,993.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Andreas G. Frank sold 3,940 shares of the company’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total transaction of $306,689.60. Following the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Several institutional investors have recently modified their holdings of HRC. Independent Portfolio Consultants Inc. raised its position in shares of Hill-Rom Holdings by 171.5% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after acquiring an additional 849 shares during the last quarter. Seven Eight Capital LP bought a new stake in shares of Hill-Rom Holdings during the 2nd quarter valued at $127,000. Acrospire Investment Management LLC raised its position in shares of Hill-Rom Holdings by 43.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after acquiring an additional 600 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Hill-Rom Holdings by 10.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock valued at $175,000 after acquiring an additional 204 shares during the last quarter. Finally, Citigroup Inc. raised its position in shares of Hill-Rom Holdings by 21.1% during the 2nd quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after acquiring an additional 433 shares during the last quarter. Institutional investors own 82.44% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Analyst Recommendations for Hill-Rom Holdings (NYSE:HRC)

What are top analysts saying about Hill-Rom Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom Holdings Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit